Procise CRP Assay Receives CE Mark
The Procise CRP assay fits the company’s strategy of developing and commercializing 2- to 5-minute point-of-care tests that are easy, immediate, and accurate.
Read More
Search Results for: point-of-care
MBio Diagnostics, SRI Partner for BARDA Contracts
MBio partners with SRI International on diagnostic programs funded by BARDA.
Read MoreMesa Biotech Developing Molecular Point-of-Care Diagnostic Test for COVID-19
Building upon the existing Accula molecular platform, Mesa’s coronavirus test aims to deliver accurate and accessible testing close to the patient, providing critical information to healthcare providers in China, the United States, and other affected countries
Read More
Roche Receives CE Mark for Accu-Chek SugarView Smartphone App
The app will enable broader access to therapy-relevant information for non-insulin-dependent people with type 2 diabetes or prediabetes.
Read MoreT2 Biosystems Appoints Industry Veteran John Sperzel as Chief Executive Officer
T2 Biosystems has announced the appointment of diagnostics industry veteran John Sperzel as president and chief executive officer, succeeding John McDonough, who will continue with his board leadership role, serving as nonexecutive chairman.
Read More